Anebulo Pharmaceuticals, Inc. ANEB
Set alert
0.24 USD -0.02 -6.92%
At close · Oct 30
0.38 +0.14 +57.81%
After hours · Oct 30, 4:00 PM ET
0.8699 Day range 0.8699
0.001 52-week range 2.65
- YTD
- -76.04%
- 1 year
- -90.83%
- Open
- 0.8699
- Prev close
- 0.26
- Mkt cap
- 9.87M
- Vol
- 100
- Avg vol
- 184
- EPS
- -0.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8699
- High
- 0.8699
- Forward P/E
- -2.49
- Beta
- -1.01
- Short ratio
- 1.94
- Inst. own
- 28.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 1.60
- 200-d avg
- 2.14
- 1y target
- 8.00
3M chart
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
Newest 20 of 21.
Analyst view
Consensus: none
Price target (mean) 8.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.08 – -0.08 | -0.11 | +27.3% | 0 | 0.0% | 1 |
| Next quarter | -0.08 | -0.08 – -0.08 | -0.06 | -33.3% | 0 | 0.0% | 1 |
| Current year | -0.33 | -0.33 – -0.33 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.33 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Oct 1, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Oct 3, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Sep 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 21, 2023 | Maxim Group | Initiated | — | Buy |
| Sep 18, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| May 18, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Feb 14, 2023 | Benchmark | Maintained | — | Speculative Buy |
| Jul 27, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| May 25, 2021 | Benchmark | Initiated | — | Buy |